J. Martin Carroll
Chairman of the Board
Pharmaceutical science
Inotek Pharamaceuticals
United States of America
Biography
Mr. Carroll most recently led Global Strategy and Development for Boehringer Ingelheim GmBH. Prior to that role, he was the President and CEO of US Businesses for Boehringer Ingelheim, overseeing an organization with revenues in the U.S. in excess of $7 billion and over 10,000 employees. His previous experience includes 25 years with Merck & Company, Inc., most recently as Executive Vice President, Customer Marketing and Sales. Mr. Carroll is currently a member of the Board of Directors at Catalent, Inc., TherapeuticsMD, Inc. and Mallinckrodt Pharmaceuticals. Mr. Carroll served in the United States Air Force, and received a Bachelor of Arts degree in Accounting and Economics from the College of the Holy Cross and a Master of Business Administration degree from Babson College.
Research Interest
Pharmaceutical science
